Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC), often reffered to as malignant hepatoma. It is the most common type of hepato cancer. Most cases of hepato cancer are as a result of either a viral hepatitis infection (hepatitis B or C), metabolic toxins such as alcohol or aflatoxin, conditions like hemochromatosis. Treatment options for HCC and prognosis are dependent on many factors but especially on tumor size, staging, and extent of hepatic injury. High-grade tumors will have a poor prognosis, while low-grade tumors may unnoticed for many years.

 

  • Hepatocellular disease
  • Fibrolamellar hepatocellular carcinoma
  • Hepatocellular cancer
  • Metastatic hepatocellular carcinoma
  • Multifocal hepatocellular carcinoma
  • Upper GI x-ray

Related Conference of Hepatocellular Carcinoma

March 18-19, 2020

International Conference on Gastroenterology and Liver

Amsterdam, Netherlands
March 18-19, 2020

11th International conference on Liver and Hepatitis

Amsterdam, Netherlands
March 30-31, 2020

7th International Conference on Hepatology

Osaka, Japan
June 24-25, 2020

15th Euro-Global Gastroenterology Conference

Rome, Italy
July 20-21, 2020

20th World Gastroenterologists Summit

Osaka, Japan
September 28-29. 2020

3rd World Liver Congress

Abu Dhabi, UAE
November 16-17, 2020

30th World Congress on Nursing

Brisbane, Australia
December 07-08 , 2020

International Congress on Gastroenterology and Liver Transplant

Auckland, Newzeland

Hepatocellular Carcinoma Conference Speakers

Recommended Sessions

Related Journals

Are you interested in